Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease
作者： William N. Hannah , Stephen A. Harrison
DOI: 10.1016/J.CLD.2015.10.008
关键词:
摘要: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome. NAFLD most common in developed countries. Weight reduction 3% to 5% associated with improved steatosis; reductions 7% are necessary for decreased inflammation; 10%, individuals may experience NAFLD/NASH remission and regression fibrosis. No specific dietary intervention has proven beneficial beyond calorie restriction. Physical activity without weight loss seems decrease steatosis. Bariatric surgery cardiovascular risk overall mortality addition steatosis, inflammation,
sci-hub.se 参考文章(65)
Jean Welsh, Joel E Kimmons, Cathleen Gillespie, Heidi Michels Blanck, Miriam B Vos, Dietary Fructose Consumption Among US Children and Adults: The Third National Health and Nutrition Examination Survey The Medscape Journal of Medicine. ,vol. 10, pp. 160- 160 ,(2008)
G Mingrone, L Castagneto-Gissey, Insulin sensitivity and secretion modifications after bariatric surgery. Journal of Endocrinological Investigation. ,vol. 35, pp. 692- 698 ,(2012) , 10.3275/8470
Monize Aydar Nogueira, Claudia Pinto Oliveira, Venâncio Avancini Ferreira Alves, José Tadeu Stefano, Lívia Samara dos Reis Rodrigues, Raquel Susana Torrinhas, Bruno Cogliati, Hermes Barbeiro, Flair José Carrilho, Dan Linetzky Waitzberg, Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial Clinical Nutrition. ,vol. 35, pp. 578- 586 ,(2016) , 10.1016/J.CLNU.2015.05.001
Gokcen Basaranoglu, Metin Basaranoglu, Elisabetta Bugianesi, Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction Hepatobiliary surgery and nutrition. ,vol. 4, pp. 109- 116 ,(2015) , 10.3978/J.ISSN.2304-3881.2014.11.05
C MATTEONI, Z YOUNOSSI, T GRAMLICH, N BOPARAI, Y LIU, A MCCULLOUGH, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. ,vol. 116, pp. 1413- 1419 ,(1999) , 10.1016/S0016-5085(99)70506-8
Ran Jin, Jean Welsh, Ngoc-Anh Le, Jeffrey Holzberg, Puneet Sharma, Diego Martin, Miriam Vos, Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients. ,vol. 6, pp. 3187- 3201 ,(2014) , 10.3390/NU6083187
Guy Bower, Tania Toma, Leanne Harling, Long R Jiao, Evangelos Efthimiou, Ara Darzi, Thanos Athanasiou, Hutan Ashrafian, Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology. Obesity Surgery. ,vol. 25, pp. 2280- 2289 ,(2015) , 10.1007/S11695-015-1691-X
Stephen A. Harrison, Will Fecht, Elizabeth M. Brunt, Brent A. Neuschwander-Tetri, Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial Hepatology. ,vol. 49, pp. 80- 86 ,(2009) , 10.1002/HEP.22575
Philippe Mathurin, Antoine Hollebecque, Laurent Arnalsteen, David Buob, Emmanuelle Leteurtre, Robert Caiazzo, Marie Pigeyre, Hélène Verkindt, Sébastien Dharancy, Alexandre Louvet, Monique Romon, François Pattou, Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease Gastroenterology. ,vol. 137, pp. 532- 540 ,(2009) , 10.1053/J.GASTRO.2009.04.052
Manal F Abdelmalek, Ayako Suzuki, Cynthia Guy, Aynur Unalp‐Arida, Ryan Colvin, Richard J Johnson, Anna Mae Diehl, Nonalcoholic Steatohepatitis Clinical Research Network, None, Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. ,vol. 51, pp. 1961- 1971 ,(2010) , 10.1002/HEP.23535